Navigation Links
Concentric Medical(R) Announces Co-Marketing Agreement With InTouch Health(R) to Advance Acute Ischemic Stroke Care

MOUNTAIN VIEW, Calif., Aug. 12 /PRNewswire/ -- Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients, announced today that it has entered into a co-marketing agreement with InTouch Health to facilitate the advancement of stroke care in the U.S. Concentric Medical and InTouch Health will work with hospitals to create centers of excellence for treating acute ischemic stroke, developing comprehensive programs that offer patients the broadest range of options in acute stroke intervention.

Concentric Medical provides Merci Retrieval Systems(TM), as well as tools, resources and physician training to help hospitals provide state-of-the-art care for patients suffering from ischemic stroke. InTouch Health provides Remote Presence technology, which is a next generation telemedicine solution combining the power of robotics, wireless, and the Internet to achieve full physician coverage for patients that present to the hospital with acute stroke symptoms.

Maria Sainz, President and CEO of Concentric Medical said, "Concentric Medical is excited to team with InTouch Health to bring about real change in the way hospitals address the care of acute ischemic stroke and extends the reach of their growing stroke networks. Prompt access to physicians who can provide all interventional options including Concentric's Merci Retrieval System is a critical component in the effective treatment of this disease."

Yulun Wang, Ph.D., Chairman and CEO of InTouch Technologies said, "I am very pleased to announce this agreement with Concentric Medical. Together we have an opportunity to give stroke patients everywhere a better chance of survival by delivering faster and more efficient access to state-of-the-art stroke expertise and care through our Remote Presence telestroke networks."

About Concentric Medical

Concentric Medical is located in Mountain View, California, and was founded in August 1999. The company manufactures and markets the Merci Retrieval System, which is a minimally invasive device that is delivered by a neurointerventionalist into the brain to restore blood flow by engaging, capturing and removing blood clots that cause ischemic stroke. The Merci Retrieval System is available in over 250 leading stroke centers around the world, and has been the subject of two successful clinical trials, MERCI and Multi MERCI. Concentric Medical estimates that over 8,000 patients have been treated with its devices. For more information about Concentric Medical, please visit

About InTouch Health

InTouch Technologies, Inc. (d.b.a. InTouch Health) is a privately held company based in Santa Barbara, CA. The company has pioneered Remote Presence technology for healthcare providers. Through its RP-7 Remote Presence Robotic System, a proprietary mobile robotic and communications platform, doctors are able to consult with hospital-based patients and staff more easily and frequently. The InTouch Health solution leverages the time and expertise of healthcare professionals across multiple care facilities, improving the efficiency and effectiveness of care delivery. The Company now has over 200 RP-7 systems deployed in acute care settings that are utilized for a range of clinical applications including stroke and multidisciplinary outreach, remote critical care coverage, on-call services and rounding. For more information about InTouch Health please visit

Media Contact: Andrew Gordon (650) 810-1701

SOURCE Concentric Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Concentric Wins Full-Service Professional Assignment From Biopharm Innovator Neuromed
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
5. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
6. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
7. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris ... that its business and prospects remain fundamentally strong ... Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation to ... completion following review of the final interim efficacy ... 2 Primary Endpoint in men with heavily pretreated ...
(Date:11/25/2015)... CA (PRWEB) , ... November 25, 2015 , ... ... genomics company uBiome, were featured on AngelList early in their initial angel funding ... an AngelList syndicate for individuals looking to make early stage investments in the ...
(Date:11/24/2015)... 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will ... New York on Wednesday, December 2 at 9:30 a.m. ... and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola ... a corporate overview. --> th Annual Oppenheimer Healthcare ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris ... of IIROC on behalf of the Toronto Stock Exchange, ... release there are no corporate developments that would cause ... --> --> About Aeterna ... . --> Aeterna Zentaris is a ...
Breaking Biology Technology:
(Date:11/18/2015)... Nov. 18, 2015  As new scientific discoveries deepen ... and other healthcare providers face challenges in better using ... patients. In addition, as more children continue to survive ... adulthood and old age. John M. Maris, ... Hospital of Philadelphia (CHOP) . --> ...
(Date:11/17/2015)... , Nov. 17, 2015 Pressure BioSciences, Inc. ... the development and sale of broadly enabling, pressure cycling ... sciences industry, today announced it has received gross proceeds ... million Private Placement (the "Offering"), increasing the total amount ... or more additional closings are expected in the near ...
(Date:11/11/2015)... MedNet Solutions , an innovative SaaS-based eClinical technology company that ... announce that it will be a Sponsor of the ... held November 17-19 in Hamburg , Germany.  ... iMedNet , MedNet,s easy-to-use, proven and affordable eClinical ... able to deliver time and cost savings of up to ...
Breaking Biology News(10 mins):